Abstract:Objective: Cerebral infarction treatments are most effective if used early after stroke symptoms occur. Also, early detection is crucial for delaying and improving cognitive impairment. This study investigated the relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (Non-HDL-C/HDL-C), which reflects the entire burden of the cholesterol transported in atherogenic lipoproteins, and the level of β-amyloid 1-42 (Aβ-1-42), a major component of cerebrovascular amyloid deposits, in peripheral blood and cognitive dysfunction secondary to cerebral infarction. Methods: A total of 83 patients with cerebral infarction admitted to Bozhou People's Hospital between June 2019 and June 2022 were assessed. The patients were divided into two groups based on their Mini-Mental State Scale (MMSE) scores: cognitive dysfunction group (n = 30) and non-cognitive dysfunction group (n = 53). In addition, a control group comprising 34 patients with transient cerebral insufficiency or cerebrovascular stenosis was selected. The groups were compared in terms of various clinical factors, including gender, age, hypertension, hyperlipidemia, lipid indexes, Non-HDL-C/HDL-C, and Aβ1-42 levels. Logistic regression analysis was used to identify the risk factors associated with cognitive dysfunction. Results: The results showed that hypertensive patients with cognitive dysfunction secondary to cerebral infarction had a higher proportion of frontal lobe, temporal lobe, and thalamus involvement and lower scores on the MMSE compared to the non-cognitive impairment group and control group (p < 0.05). Additionally, the levels of homocysteine (HCY), Non-HDL-C/HDL-C, and Aβ1-42 in peripheral blood were significantly higher in hypertensive patients with cognitive dysfunction compared to the other two groups (all p < 0.05) and were identified as risk factors for cognitive dysfunction secondary to cerebral infarction. Peripheral blood levels of Non-HDL-C/HDL-C and Aβ1-42 are risk factors for secondary cognitive dysfunction following a cerebral infarction. Conclusion: These data have important clinical implications for understanding the mechanisms underlying cognitive dysfunction in individuals with cerebrovascular disorders, potentially leading to new early interventions for preventing or treating such diseases.

Changes in HIF-1α, VEGF, NGF and BDNF Levels in Cerebrospinal Fluid and Their Relationship with Cognitive Impairment in Patients with Cerebral Infarction

Changes In Hif-1 Alpha, Vegf, Ngf And Bdnf Levels In Cerebrospinal Fluid And Their Relationship With Cognitive Impairment In Patients With Cerebral Infarction

Plasma Level of Endothelin-1 and Vascular Endothelial Growth Factor in Vascular Congnitive Impairment and Dementia

Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects

The potential role of vascular endothelial growth factor as a new biomarker in severe intracerebral hemorrhage

Dynamic Changes of Insulin Like Growth Factor-1 Signaling Pathway in the Rat Hippocampus Following Chronic Cerebral Hypoperfusion

The Clinical Significance of Vascular Endothelial Growth Factor with Acute Cerebral Infarction

Correlation between Non-HDL-C/HDL-C and Aβ1-42 levels in cerebral infarction-related cognitive dysfunction

Differential Expression of Vascular Endothelial Growth Factor in the Cortex and Hippocampus upon Cerebral Hypoperfusion

High-Serum Brain-Derived Neurotrophic Factor Levels Are Associated With Decreased Risk of Poststroke Cognitive Impairment

VEGF Loaded Nanofiber Membranes Inhibit Chronic Cerebral Hypoperfusion-Induced Cognitive Dysfunction by Promoting HIF-1a/VEGF Mediated Angiogenesis.

Serum Neuroglobin as a Potential Prognostic Biomarker for Cognitive Impairment After Intracerebral Hemorrhage

Changes of expression levels of vascular endothelial growth factor and its receptors in diabetes rats with cerebral infarction

VEGF attenuates 2-VO induced cognitive impairment and neuronal injury associated with the activation of PI3K/Akt and Notch1 pathway.

Correlation study of serum HIF-1αlevel and cognitive impairment after stroke

Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment

VEGF Modulates the Neural Dynamics of Hippocampal Subregions in Chronic Global Cerebral Ischemia Rats

Changes and Significance of Serum Level of Vascular Endothelial Growth Factor and Tumornecrosis Factor-α with Acute Cerebral Infarction

Altered neurovascular coupling in patients with vascular cognitive impairment: a combined ASL-fMRI analysis

Change of serum soluble intercellular adhesion molecule and basic fibroblast growth factor in patients with acute cerebral infarction and its clinical significance]

The correlation between the severity of cerebral microbleeds and serum HMGB1 levels and cognitive impairment in patients with cerebral small vessel disease